The fusion partners of NTRK, as previously described in NSCLC cases, include the TPM3, MPRIP, CD74, SQSTM1, IRF2BP2, MPRIP, ETV6, and TPR genes [24,25]. The gene discussed is IRF2BP2; the disease is non-small cell lung carcinoma.